Acadia Pharma -additional information for your consideration.:
*In total Acadia employees nearly 600 people mostly in San Diego California. The company also operates a complete medical research facility in the Netherlands.
*In almost 30 years Acadia has never made a profit.
*In the full 2023-year Acadia reported a net loss of $63.1M or 37c per share but the company hopes to break even in the next 12 months.
*Revenue growth seems to be the only important analyst measure in valuing this stock.
*Acadia share price currently is almost trading at its 52-week low.
*Previous acquisition rumours appear to have disappeared.
*Baker Bros Advisors [hedge fund] own 26.0% of Acadia shares and their investment here represents 14.9% of the entire Baker Bros portfolio.
*Baker Bros have been invested in Acadia since 2010 and obviously bought in very cheaply.
*Julian Baker has been on the Acadia BOD since 2015.
*Acadia CEO Steve Davis is a CPA and lawyer. He is also a director of Bellicum Pharma.
Baker Bros have a 19.9% stake in this company. Over the past year Bellicum lost 91.1% of its share value.
The Baker Bros exit strategy is still the big unknown here.
Kens
Acadia Pharma -additional information for your...
-
- There are more pages in this discussion • 287 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 249 | $20.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.31 | 790 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |